Additionally, five case reports of pediatric PEL have documented NFIA with core binding factor gene rearrangements, suggesting a potentially distinct pathological subgroup of pediatric PEL [18,19,20,21,22]. The gene discussed is NFIA; the disease is primary effusion lymphoma.